Actualización en otras infecciones bacterianas crónicas: actinomicosis y brucelosis

  1. Pascual Pérez, S. 1
  2. Tinoco Racero, I. 1
  3. López Tinoco, E. 1
  4. Piñero Fernández-Reyes, M.L. 2
  1. 1 Servicios de Medicina Interna General, Enfermedades Infecciosas y Cuidados Paliativos
  2. 2 Medicina Nuclear. Hospital Universitario Puerta del Mar. Cádiz. España
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2022

Issue Title: Enfermedades infecciosas (V)

Series: 13

Issue: 53

Pages: 3100-3110

Type: Article

DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Actinomycosis is a rare granulomatous infection caused by bacteria of the Actinomyces genus. Its diagnosis, which is often not suspected, is based on visualization of the germ or of the so-called «sulfur granules» in histological samples and/or its isolation and microbiological identification. It produces nonspecific symptoms that depend on its location. It should be suspected in chronic and indolent infections that form masses or fistulas and appear to be neoplasms, lack of a cure, or relapse following the administration of antibiotics. Actinomycosis has a good prognosis. Treatment with antibiotics, especially penicillin, is given at high doses and for a long period of time. Brucellosis is a zoonosis produced by Brucella spp. Most infections occur due to contact with livestock or intake of non-pasteurized dairy products. It should be suspected in epidemiologically suitable environments in patients with prolonged fever, spondylodiscitis, sacroiliitis, orchiepididymitis, endocarditis with a negative culture, or lymphocytic meningitis. Its diagnosis depends on the disease stage and is based on direct and indirect methods. Combination therapy with tetracyclines and aminoglycosides are used to treat it.

Bibliographic References

  • Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev. 2015;28:419-42.
  • Russo TA. Actinomicosis. En: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J, eds. Harrison Principios de Medicina Interna. 20ª ed. New York, NY: McGraw-Hill Education; 2018. p.1220-3.
  • Sharma S, Hashmi MF, Valentino III DJ. Actinomycosis. Treasure Island (FL): StatPearls Publishing; 2021.
  • Russo TA. Microorganismos causantes de la actinomicosis. En: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Enfermedades infecciosas: Principios y práctica. 9ª ed. Barcelona: Elsevier España; 2020 p. 3071-81.
  • Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014;7:183-97.
  • Bonnefond S, Catroux M, Melenotte C, Karkowski L, Rolland L, Trouillier S. Clinical features of actinomycosis: A retrospecti- ve, multicenter study of 28 cases of miscellaneous presentations. Medicine (Baltimore). 2016;95:e3923.
  • Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ 2011;343:d6099.
  • Pulverer G, Schütt-Gerowitt H, Schaal KP. Human cervicofacial actinomycoses: microbiological data for 1997 cases. Clin Infect Dis. 2003;37:490-7.
  • D’Amore F, Franchini R, Moneghini L, Lombardi N, Lodi G, Sardella A. Actinomycosis of the tongue: A case report and review of literature. Antibiotics (Basel). 2020;9:124.
  • Kim SR, Jung LY, Oh IJ, Kim YC, Shin KC, Lee MK. Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients. BMC Infect Dis. 2013;13:216.
  • del Olmo Martínez L, Aller de la Fuente R, Velayos Jiménez B, Fernández Salazar L, González Hernández JM. Esophageal actinomycosis. Rev Esp Enf Dig. 2009;101:372-3.
  • Ridha A, Oguejiofor N, Al-Abayechi S, Njoku E. Intra-abdominal actinomycosis mimicking malignant abdominal disease. Case Rep Infect Dis. 2017;2017:1972023.
  • Yang SH, Li AF, Lin JK. Colonoscopy in abdominal actinomycosis. Gastrointest Endosc. 2000;51:236-8.
  • Han Y, Cao Y, Yanjun Z, Liu N, ShuZhen W, CuiQin S. A case report of pelvic actinomycosis and a literature review. Am J Case Rep. 2020;21:e922601.
  • García García A, Ramírez Durán N, Sandoval Trujillo H, Romero Figueroa M del S. Pelvic actinomycosis. Can J Infect Dis Med Microbiol. 2017;2017:9428650.
  • Qiu L, Lan L, Feng Y, Huang Z, Chen Y. Pulmonary actinomycosis imitating lung cancer on 18F-FDG PET/CT: A case report and literature review. Korean J Radiol. 2015;16:1262-5.
  • Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time of flight mass spectrometry. Clin Infect Dis. 2009;49(4):543-51.
  • Moghimi M, Salentijn E, Debets Ossenkop Y, Karagozoglu KH, Forouzanfar T. Treatment of cervicofacial actinomycosis: A report of 19 cases and review of literature. Med Oral Patol Oral Cir Bucal. 2013;18:e627-32.
  • Mensa Pueyo J, Soriano Viladomiu. Guia de terapeútica antimicrobiana 2021. Molins de Rei (Barcelona): Ed. Antares 2021. p. 298-300.
  • Marchand Austin A, Rawte P, Toye B, Jamieson FB, Farrell DJ, Patel SN. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011. Anaerobe. 2014;28SupplC):120-5.
  • Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352:2325-36.
  • Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucelosis. Lancet Infect Dis. 2006;6:91-9.
  • Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci. 2006;63:2229-36.
  • Mantur BG, Mangalgi SS, Mulimani M. Brucella melitensis, a sexually transmissible agent? Lancet. 1996;347:1763.
  • Gul HC, Erdem H. Brucellosis (Brucella Species). En: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9ª ed. Philadelphia: Elsevier; 2020. p. 2753-8.
  • Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systema- tic review and meta-analysis. PLoS Negl Trop Dis. 2012;6:e1929.
  • Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007;25:188-202.
  • Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2019;33:e00073-19.
  • Mantur BG, Mangalgi SS. Evaluation of conventional Castañeda and lysis centrifugation blood culture techniques for diagnosis of human brucellosis. J Clin Microbiol 2004;42:4327-8.
  • Bosilkovski M, Katerina S, Zaklina S, Ivan V. The role of Brucella-capt test for follow-up patients with brucellosis. Comp Immunol Microbiol Infect Dis. 2010;33:435-42.
  • Nielsen K. Diagnosis of brucellosis by serology. Vet Microbiol. 2002;90:447-59.
  • Kaden R, Ferrari S, Alm E, Wahab T. A novel real-time PCR assay for specific detection of Brucella melitensis. BMC Infect Dis. 2017;17:230.
  • Casao MA, Smits HL, Navarro E, Solera J. Clinical utility of a dipstick assay in patients with brucellosis: correlation with the period of evolution of the disease. Clin Microbiol Infect. 2003;9:301-30.
  • Al-Tawfiq JA. Therapeutic options for human brucellosis. Expert Rev Anti Infect Ther. 2008;6:109-20.
  • Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007;4:e317.
  • Al-Madfaa RO, Alalawi MA, Basudan LO, Alhejaili SF, Eljaaly K, Madani TA. Dual versus triple therapy for uncomplicated brucellosis: A retrospective cohort study. J Infect Dev Ctries. 2020 14(12):1380-86.
  • Traxler RM, Guerra MA, Morrow MG. Review of Brucellosis cases from laboratory exposures in the United States in 2008 to 2011 and improved strategies for diseases prevention. J Clin Microbiol. 2013;51:31-2.
  • Bosilkovski M, Keramat F, Arapovic J. The current therapeutical strategies in human brucellosis. Infection. 2021;49(5):823-32.
  • Alavi S, Alavi L. Treatment of brucellosis: a systematic review of studies in recent twenty years. Casp J Intern Med. 2013;4:636-41.
  • Arias Villate C, García Casallas C. Update of antibiotic therapy of brucellosis. En: Ranjbar M, Nojomi M, Mascellino M, eds. New insight brucella infect foodborne dis intechopen. London (UK): IntechOpen; 2020.
Data source: Dialnet